NCT01737645

Brief Summary

This study is to determine if there is a rise in eye pressure, when patients are placed in a position where the head is lower than the rest of the body during long surgeries.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2012

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 16, 2012

Completed
5 months until next milestone

Study Start

First participant enrolled

August 1, 2012

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 29, 2012

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

July 17, 2014

Status Verified

July 1, 2014

Enrollment Period

1.9 years

First QC Date

March 16, 2012

Last Update Submit

July 16, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • To compare the percent change from baseline IOP reading to the peak IOP reading during steep Trendelenburg positioning in thin subjects vs morbidly obese subjects.

    Measured from baseline IOP to peak IOP during steep Trendelenburg. The overall time frame for which the outcome measure is assessed is up to 3 years.

Secondary Outcomes (2)

  • To determine rate of rise of IOP during steep Trendelenburg positioning

    The time during the surgery when the patient is in steep Trendelenburg positioning. The overall time frame for which the outcome measure is assessed is up to 3 years.

  • To compare peak IOP and rise of IOP during steep Trendelenburg positioning in thin vs morbidly obese subjects.

    The time during the surgery when the patient is in steep Trendelenburg positioning. The overall time frame for which the outcome measure is assessed is up to 3 years.

Study Arms (2)

obese patients

BMI (body mass index) more than or equal to 35 kg/m2 (weight in kilograms divided by the square of the height in metres)

Thin patients

BMI less than or equal to 30 kg/m2

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult Subjects undergoing prolonged procedures expected to be in steep Trendelenburg position. Procedure must be scheduled for \> 3 hours, eg. robotic prostatectomy, hysterectomy, and cystectomy.

You may qualify if:

  • Subjects undergoing prolonged procedures (scheduled \>3hr) in steep Trendelenburg position (eg. robotic prostatectomy, hysterectomy, cystectomy)
  • Morbidly obese subjects: BMI ≥ 35 kg/m2
  • Thin subjects: BMI ≤ 30 kg/m2
  • Age 18-70
  • ASA (American Society of Anesthesiologists) physical status classification I, II, or III

You may not qualify if:

  • Known history of glaucoma
  • Note:if initial IOP is noted to be \>21mmHg (millimeters of mercury), patient will be excluded from study and an ophthalmology consultation will be obtained.Surgery will not be postponed.
  • Recent use of IOP lowering topical ophthalmic agents
  • Allergy to latex or proparacaine hydrochloride ophthalmic solution
  • Patients with active corneal epithelial defects or history of recurrent corneal erosion
  • Patients with underlying disorders that can directly increase intraocular pressure (thyroid eye disease, intra orbital tumors, orbital vascular malformation, Sturge-Weber disease, carotid or dural cavernous arteriovenous malformation, cavernous sinus pathology)
  • History of corneal surgery, to include LASIK (laser-assisted in-situ keratomileusis)
  • Any eye surgery within prior 1 month
  • Known pregnancy
  • Cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

William Beaumont Hospital

Royal Oak, Michigan, 48073, United States

Location

Study Officials

  • Roy G Soto, MD

    Corewell Health East

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 16, 2012

First Posted

November 29, 2012

Study Start

August 1, 2012

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

July 17, 2014

Record last verified: 2014-07

Locations